TPM3 and cancer: This ongoing research into the molecular mechanisms of TPM3‐ALK fusions and their role in cancer pathogenesis continues to provide valuable insights into potential therapeutic strategies and the development of more effective treatments for patients with ALK‐rearranged tumors [17].